GlassScriptPhysician profile
Christopher S Doh
NPI 1891323325
$5,334.21
in general payments reported to CMS, 2019-2025
8 companies · $4,773 in 2025
The $4,773 reported for 2025 was more than what 94% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $561 · 2025: $4,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,642 · Travel and Lodging: $1,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,641.71 |
| Travel and Lodging | $1,692.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,188.23 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Globus Medical, INC. | $469.37 | 2025 | Senza, Vyrsa V1 |
| Saluda Medical Americas, INC. | $245.24 | 2025 | Evoke |
| Spr Therapeutics, INC | $195.53 | 2025 | Sprint Pns System |
| Abbott Laboratories | $163.88 | 2025 | Proclaim |
| Ferring Pharmaceuticals INC. | $34.52 | 2025 | Euflexxa |
| Collegium Pharmaceutical, INC. | $21.44 | 2025 | Xtampza |
| Avanos Medical | $16.00 | 2025 | Coolief Cooled Radiofrequency |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Doh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.